← FDA Drug Approvals (Drugs@FDA)
METFORMIN HYDROCHLORIDE AND SITAGLIPTIN PHOSPHATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ZYDUS PHARMS USA INC · Approved 2026-06-30
Drug application
- FDA Application #
ANDA208535- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- METFORMIN HYDROCHLORIDE AND SITAGLIPTIN PHOSPHATE
- Generic name
- Metformin Hydrochloride
- Active ingredients
- METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- None (Tentative Approval)
- Sponsor
- ZYDUS PHARMS USA INC
- First approval
- 2026-06-30
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown